US2009131340A1PendingUtilityA1
Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
Est. expiryDec 13, 2014(expired)· nominal 20-yr term from priority
A61P 37/04A61P 43/00A61P 37/08A61P 29/00A61P 17/00A61K 8/602A61Q 17/04Y10T428/193A61K 31/70A61K 8/37A61Q 19/08Y10T428/195A61K 2800/522A61K 8/361A61K 31/19A61K 8/498A61K 8/9789A61Q 19/001A61K 8/365A61K 45/06A61K 8/36A61Q 5/00A61Q 19/00A61K 31/192
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating or prophylactically treating immunosuppression or allergic and inflammatory symptoms of skin caused by UVB radiation which comprises applying to the skin a cosmetic or dermatological composition which comprises one or more flavonoids.
Claims
exact text as granted — not AI-modified1 . A method of treating or prophylactically treating immunosuppression of skin cells induced by UVB radiation, wherein the method comprises topically applying to skin of a person in need thereof an effective amount therefor of a cosmetic or dermatological composition comprising one or more compounds selected from chalcones and glycosides thereof.
2 . The method of claim 1 , wherein immunosuppression is treated.
3 . The method of claim 1 , wherein the composition further comprises one or more cinnamic acid derivatives.
4 . The method of claim 1 , wherein the composition further comprises one or more antioxidants.
5 . The method of claim 4 , wherein the one or more antioxidants comprise at least one of tocopherol and a derivative thereof.
6 . The method of claim 1 , wherein the composition further comprises one or more of alpha-glucosylrutin, alpha-glucosylmyricitrin, alpha-glucosylquercitrinin, alpha-glucosylquercitrin, rutin, chrysin, kaempferol, myricetin, rhamnetin, apigenin, luteolin, naringin, hesperidin, naringenin, hesperitin, morin, phloridzin, diosmin, fisetin, vitexin, neohesperidin, flavone and genistein.
7 . The method of claim 1 , wherein the composition comprises from 0.01% to 10% by weight of the one or more compounds, based on a total weight of the composition.
8 . The method of claim 7 , wherein the composition comprises from 0.1% to 6% by weight of the one or more compounds.
9 . The method of claim 1 , wherein the cosmetic or dermatological composition comprises an emulsion.
10 . The method of claim 1 , wherein the cosmetic or dermatological composition comprises a gel.
11 . A method for treating or prophylactically treating one or more of allergic and inflammatory symptoms of skin caused by UVB radiation, wherein the method comprises topically applying to the skin a cosmetic or dermatological composition comprising one or more compounds selected from alpha-glucosylrutin, alpha-glucosylmyricitrin, alpha-glucosylquercitrinin, alpha-glucosylquercitrin, quercetin, rutin, chrysin, kaempferol, myricetin, rhamnetin, apigenin, luteolin, naringin, hesperidin, naringenin, hesperitin, morin, phloridzin, diosmin, fisetin, vitexin, neohesperidin, dihydrochalcone, flavone, genistein, and chalcones and glycosides thereof.
12 . The method of claim 11 , wherein allergic symptoms are treated or prophylactically treated.
13 . The method of claim 11 , wherein allergic symptoms are treated or prophylactically treated.
14 . The method of claim 11 , wherein the composition further comprises one or more antioxidants.
15 . The method of claim 14 , wherein the one or more antioxidants comprise at least one of tocopherol and a derivative thereof.
16 . The method of claim 11 , wherein the composition comprises from 0.01% to 10% by weight of the one or more compounds, based on a total weight of the composition.
17 . The method of claim 16 , wherein the composition comprises from 0.1% to 6% by weight of the one or more compounds.
18 . The method of claim 11 , wherein the cosmetic or dermatological composition comprises an emulsion.
19 . The method of claim 11 , wherein the cosmetic or dermatological composition comprises a gel.
20 . The method of claim 11 , wherein the one or more compounds comprise alpha-glucosylrutin.Join the waitlist — get patent alerts
Track US2009131340A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.